Gw&K Investment Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Gw&K Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $158 - $211	81 New	81 $0
Q4 2019 Feb 10, 2020	SELL	$2.65 - $5.56 $1,025 - $2,151	-387 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$2.29 - $7.1 $886 - $2,747	387 New	387 $1,000
Q2 2019 Aug 06, 2019	SELL	$6.44 - $14.29 $11.6 Million - $25.8 Million	-1,805,274 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$11.87 - $14.84 $158,618 - $198,306	-13,363 Reduced 0.73%	1,805,274 $25.6 Million
Q4 2018 Feb 07, 2019	SELL	$13.09 - $21.49 $3.03 Million - $4.97 Million	-231,128 Reduced 11.28%	1,818,637 $24.6 Million
Q3 2018 Nov 06, 2018	BUY	$16.4 - $24.27 $1.52 Million - $2.25 Million	92,859 Added 4.75%	2,049,765 $45.5 Million
Q2 2018 Aug 07, 2018	BUY	$13.95 - $20.2 $27.3 Million - $39.5 Million	1,956,906 New	1,956,906 $32.1 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.